- Home
- / Yungjin Pharm
Yungjin Pharm
Stock Price
₩2.4 K
2024-10-29
Market Capitalization
₩437.1 B
2024-10-29
Revenue
₩252 B
FY, 2024
Yungjin Pharm Summary
Company Summary
- Overview
- Yungjin Pharm is a company that develops and distributes pharmaceutical products. It offers a range of antibiotics and medications focusing on cardiovascular, endocrine, respiratory, inflammatory, fungal, and other diseases. In addition, the company provides vitamins, supplements, cosmetics, and tonic drinks.
- Type
- Public
- Status
- Active
- Founded
- 1952
- Website
- http://eng.yungjin.co.kr/
- Cybersecurity rating
- ESG rating
Table of Contents
Yungjin Pharm Financials
Summary Financials
- Revenue (Q2, 2025)
- ₩62.5B
- Gross profit (Q2, 2025)
- ₩21.6B
- Net income (Q2, 2025)
- ₩338.8M
- Cash (Q2, 2025)
- ₩11.0B
- EBIT (Q2, 2025)
- ₩1.6B
- Enterprise value
- $501.2B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026